Report Detail

Request for Sample of this report

Pharma & Healthcare Global Subcutaneous Immunoglobulins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2974989
    • |
  • 18 February, 2019
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Scope of the Report:
The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.
Market competition is intense. In United States, only Shire (Baxalta), Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Subcutaneous Immunoglobulins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Subcutaneous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Shire (Baxalta)
Grifols
CSL

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
10% Purity
20% Purity

Market Segment by Applications, can be divided into
Primary Immunodeficiency
Secondary Immunodeficiency
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Immunoglobulins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Subcutaneous Immunoglobulins, with price, sales, revenue and global market share of Subcutaneous Immunoglobulins in 2017 and 2018.
Chapter 3, the Subcutaneous Immunoglobulins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Immunoglobulins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Subcutaneous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Subcutaneous Immunoglobulins Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 10% Purity
      • 1.2.2 20% Purity
    • 1.3 Market Analysis by Applications
      • 1.3.1 Primary Immunodeficiency
      • 1.3.2 Secondary Immunodeficiency
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Shire (Baxalta)
      • 2.1.1 Business Overview
      • 2.1.2 Subcutaneous Immunoglobulins Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Grifols
      • 2.2.1 Business Overview
      • 2.2.2 Subcutaneous Immunoglobulins Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 CSL
      • 2.3.1 Business Overview
      • 2.3.2 Subcutaneous Immunoglobulins Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Subcutaneous Immunoglobulins Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Subcutaneous Immunoglobulins Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Subcutaneous Immunoglobulins Market Analysis by Regions

    • 4.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 4.3 Europe Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 4.5 South America Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)

    5 North America Subcutaneous Immunoglobulins by Country

    • 5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Country
      • 5.1.1 North America Subcutaneous Immunoglobulins Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Subcutaneous Immunoglobulins Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 5.3 Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)

    6 Europe Subcutaneous Immunoglobulins by Country

    • 6.1 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Subcutaneous Immunoglobulins Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Subcutaneous Immunoglobulins Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 6.3 UK Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 6.4 France Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 6.5 Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 6.6 Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Subcutaneous Immunoglobulins by Country

    • 7.1 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue and Market Share by Country (2014-2019)
    • 7.2 China Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 7.3 Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 7.4 Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 7.5 India Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)

    8 South America Subcutaneous Immunoglobulins by Country

    • 8.1 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Country
      • 8.1.1 South America Subcutaneous Immunoglobulins Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Subcutaneous Immunoglobulins Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Subcutaneous Immunoglobulins by Countries

    • 9.1 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2014-2019)

    10 Global Subcutaneous Immunoglobulins Market Segment by Type

    • 10.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2014-2019)
    • 10.2 10% Purity Sales Growth and Price
      • 10.2.1 Global 10% Purity Sales Growth (2014-2019)
      • 10.2.2 Global 10% Purity Price (2014-2019)
    • 10.3 20% Purity Sales Growth and Price
      • 10.3.1 Global 20% Purity Sales Growth (2014-2019)
      • 10.3.2 Global 20% Purity Price (2014-2019)

    11 Global Subcutaneous Immunoglobulins Market Segment by Application

    • 11.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2014-2019)
    • 11.2 Primary Immunodeficiency Sales Growth (2014-2019)
    • 11.3 Secondary Immunodeficiency Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Subcutaneous Immunoglobulins Market Forecast (2019-2024)

    • 12.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Subcutaneous Immunoglobulins Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Subcutaneous Immunoglobulins Market Forecast (2019-2024)
      • 12.2.2 Europe Subcutaneous Immunoglobulins Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast (2019-2024)
      • 12.2.4 South America Subcutaneous Immunoglobulins Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast (2019-2024)
    • 12.3 Subcutaneous Immunoglobulins Market Forecast by Type (2019-2024)
      • 12.3.1 Global Subcutaneous Immunoglobulins Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2019-2024)
    • 12.4 Subcutaneous Immunoglobulins Market Forecast by Application (2019-2024)
      • 12.4.1 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Subcutaneous Immunoglobulins . Industry analysis & Market Report on Subcutaneous Immunoglobulins is a syndicated market report, published as Global Subcutaneous Immunoglobulins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Subcutaneous Immunoglobulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,742.24
      		4,113.36
      		5,484.48
      		3,201.60
      		4,802.40
      		6,403.20
      		541,557.60
      		812,336.40
      		1,083,115.20
      		290,162.40
      		435,243.60
      		580,324.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo